Abstract
AbstractBackgroundMonkeypox (Mpox) infections are considered a public health emergency, prompting the need for the administration of a preventative vaccine to high‐risk individuals.ObjectivesTo describe the clinical course of dermatologic reactions to Mpox vaccine over time.MethodsSeven recipients of the Mpox vaccine, administered via intradermal injection, were observed over time, and the dermatologic reactions to this vaccine were recorded.ResultsAll seven recipients experienced mild to moderate localized reactions to Mpox vaccine to either the primary or booster injections. These reactions were characterized by erythema, induration and pruritus. These reactions eventually healed without any sustained reactions, eschar or scarring. None of the recipients experienced systemic reactions or widespread cutaneous eruptions.ConclusionsIntradermal injections of Mpox vaccine result in mild to moderate injection site reactions, most likely representing a vigorous cell‐mediated immune response. In all cases, the injection sites healed without complications.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
